THIS ANNOUNCEMENT IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

FOR IMMEDIATE RELEASE

20 March 2025

One Health Group plc

("One Health" or the "Company")

Admission to trading on AIM and first day of dealings

One Health Group plc (AIM: OHGR), a provider of NHS-funded medical procedures, is pleased to announce the admission of its entire issued share capital being 13,709,615 ordinary shares of 0.5 pence each ("Ordinary Shares") to trading on AIM, a market operated by the London Stock Exchange ("Admission").

In conjunction with Admission, the Company has completed a successful capital raising of approximately  £7.8 million (before expenses) through a placing of new and existing Ordinary Shares with certain institutional and other investors, a retail offer and an open offer at a price of 180 pence per Ordinary Share (the "Capital Raising"). The net proceeds from the Capital Raising will be used primarily to fund (alongside existing cash) the Company's first owned surgical hub through to operation. The surgical hub is expected to be operational within one year of construction starting and deliver between £6 million to £9 million of revenue per annum and is anticipated to be earnings enhancing in its first full year of operation. 

Admission will take place and dealings in the Ordinary Shares will commence at 8:00 a.m. today under the TDIM: 'OHGR' and ISIN GB00BNNT0595. Cancellation of the Company's Ordinary Shares on the Apex Segment of the AQSE Growth Market will take place simultaneously with Admission.

Further information in relation to Admission can be found in the Company's announcement from 19 February 2025. An appendix to the Schedule One, as well as information required pursuant to AIM Rule 26, is available on the Company's website at https://www.onehealth.co.uk/investors

Adam Binns, Chief Executive Officer of One Health, commented: "I am delighted to announce One Health's admission to AIM. This is a pivotal step in advancing our mission to provide NHS-aligned healthcare through patient choice and our scalable surgical hubs and patient centric service. This milestone, bolstered by a successful capital raising and strong institutional investor confidence, will enable strategic expansion while maintaining our commitment to reducing patient waiting times and delivering clinical excellence with sustainable growth. I extend my gratitude to our team, advisers, and shareholders for their support as we commence our next chapter supported by our listing on AIM. I am excited about the prospects for the business, particularly our inaugural surgical hub,  which will integrate operational excellence and technological innovation to benefit NHS patients and the broader healthcare system."

Terms used but not defined in this announcement have the same meaning as set out in the Company's announcement released at 7:00 a.m. on 19 February 2025. For more information, please contact:

About One Health Group plc

One Health engages over 70 NHS Consultants (excluding anaesthetists) who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and in the year to March 2024 provided much needed care to 13,266 new patients, through almost 34,000 consultations and over 6,000 surgical procedures. One Health deploys surgeons and anaesthetists that are mostly employed by the NHS, on a subcontracted basis. It currently works with over 100 professionals across 9 independent hospitals and 37 outreach clinics. Within these community-based outreach clinics all consultations and post operative physiotherapy is delivered where required, reducing patient inconvenience and excess travel.

One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. One Health has also sought to expand geographically from its Head Office in Sheffield into neighbouring counties which meet these criteria. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue of over £23 million in the year to 31 March 2024 was derived from over 60 NHS commissioning bodies in addition to contracts with local NHS Hospital Trusts to transfer their internal waiting list patients to One Health for quicker treatment.

One Health's business model has focused to date on four main areas: orthopaedics, spine, general surgery and gynaecology. The split of inpatient procedures in the year to 31 March 2024 was as follows: orthopaedics 46% spine 22% general surgery 22% gynaecology 10%.

Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.

Further information on the Company can be found on its website at www.onehealth.co.uk.

The Company's LEI is 984500DC689F5BAD8732.